Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European approval for Takeda's Alunbrig in ALK+ advanced non-small cell lung cancer

pharmafileNovember 29, 2018

Tag: Alunbrig , NSCLC , CHMP

PharmaSources Customer Service